Literature DB >> 2085144

Cellular and morphological changes in lymphoid organs after a single injection of interleukin 1 alpha in the mouse.

A Marusić1, I Djikić, M Marusić.   

Abstract

We investigated the effects of a single i.v. injection of recombinant human interleukin 1 alpha (IL-1 alpha) on the morphology and the cellularity of several lymphoid organs in normal mice. The injection of 100 U of IL-1 alpha resulted in maximal neutrophilia and leukocytosis at 1 h. By 72 h, the numbers of mononuclears, but not that of polymorphonuclears, returned to baseline levels. Absolute increase in mononuclears was paralleled by relative lymphopenia. Changes in the peripheral blood coincided with rapid decrease in the spleen cellularity and white pulp volume (especially the marginal zone), and an increase in the red pulp volume. Bone marrow cellularity was increased at 1 h, but returned to control levels by 6 h after IL-1 injection. Thymus cell depletion and cortex atrophy were maximal at 6 h and could be observed throughout the experiment. These findings indicate that leukocytosis induced by a single i.v. injection of IL-1 alpha in normal mice is concomitant with a rapid cell depletion of the spleen and thymus. Morphological and cellular changes in lymphoid organs may represent the mobilization of immunocompetent cells during the development of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085144     DOI: 10.1007/BF01997620

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  11 in total

1.  Alterations in megakaryocyte and platelet compartments following in vivo IL-1 beta administration to normal mice.

Authors:  D E Williams; P J Morrissey
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

2.  In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.

Authors:  C S Johnson; D J Keckler; M I Topper; P G Braunschweiger; P Furmanski
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

3.  Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alpha.

Authors:  K W McIntyre; J Unowsky; W DeLorenzo; W Benjamin
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

4.  The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation.

Authors:  T R Ulich; J del Castillo; K Guo; L Souza
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

5.  Immunosuppression induced by talc granulomatosis in the rat.

Authors:  I Radić; I Vucak; J Milosević; A Marusić; S Vukicević; M Marusić
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

6.  Mechanisms of tumor necrosis factor alpha-induced lymphopenia, neutropenia, and biphasic neutrophilia: a study of lymphocyte recirculation and hematologic interactions of TNF alpha with endogenous mediators of leukocyte trafficking.

Authors:  T R Ulich; J del Castillo; R X Ni; N Bikhazi; L Calvin
Journal:  J Leukoc Biol       Date:  1989-02       Impact factor: 4.962

7.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Authors:  S Okusawa; J A Gelfand; T Ikejima; R J Connolly; C A Dinarello
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

8.  Interleukin-1 enhances murine granulopoiesis in vivo.

Authors:  L C Stork; V M Peterson; C H Rundus; W A Robinson
Journal:  Exp Hematol       Date:  1988-02       Impact factor: 3.084

Review 9.  Interleukin-1 and the response to injury.

Authors:  E Kaplan; C A Dinarello; J A Gelfand
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

10.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Authors:  K J Tracey; H Wei; K R Manogue; Y Fong; D G Hesse; H T Nguyen; G C Kuo; B Beutler; R S Cotran; A Cerami
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.